Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab

Ann Rheum Dis. 2011 Jun;70(6):1164-5. doi: 10.1136/ard.2010.132845. Epub 2010 Oct 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Diabetes Mellitus, Type 2 / blood*
  • Follow-Up Studies
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Receptors, Interleukin-6 / immunology

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Glycated Hemoglobin A
  • Receptors, Interleukin-6
  • hemoglobin A1c protein, human
  • tocilizumab